Lung cancer diagnosis rates were higher among individuals who were LCS adherent vs nonadherent during both rounds T1 (59 of 6141 [1.0%; 95% CI, 0.7%-1.2%] vs 8 of 3892 [0.2%; 95% CI, 0.1%-0.4%]; P < .001) and T2 (63 of 5028 [1.3%; 95% CI, 1.0%-1.6%] vs 12 of 4938 [0.2%;
…Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 6 |
| 2026 | 0 |
Search Results
45 results
Results by year
RESULTS: After modifying LCS eligibility confirmation processes, patients receiving S-LDCT who met guidelines-based LCS eligibility criteria increased from 45.6 to 92.7% (P < 0.001). Prior to changes, patients were older (68 vs. 67 years; P = 0.001), less likely
…FINDINGS: Proactive iCare improved total SGRQ by 7-9 units (p < 0.0001), symptom SGRQ by 9 units (p<0.0001), activity SGRQ by 6-7 units (p<0.001) and impact SGRQ by 7-11 units (p<0.0001) at 3, 6 and 9 months compared with Usual Care. Proact
…FINDINGS: Proactive iCare improved total SGRQ by 7-9 units (p < 0.0001), symptom SGRQ by 9 units (p<0.0001), activity SG
…Adherence to both annual LCS (34.8% vs. 76.1%; P < 0.001) and recommended follow-up care (63.9% vs. 74.6%; P < 0.001) was lower at decentralized compared with centralized programs. Among individuals with negative baseline screens, a racial disparity in adheren
…Adherence to both annual LCS (34.8% vs. 76.1%; P < 0.001) and recommended follow-up care (63.9% vs. 74.6%; P < 0.001) wa
…